Prescient Therapeutics LimitedASX: PTX

US FDA Grants Orphan Drug Designation to PTX-100 for PTCL

Jul 15, 2022 at 3:48 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment